Related Experiment Video
Updated: Nov 22, 2025

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
A predictive model of inappropriate use of medical tests and medications in Bronchiolitis
Jefferson Antonio Buendía1,2,3, Carlos Andrés Rodríguez1,2,3
1Grupo de Investigación en Farmacología y Toxicología (INFARTO), Universidad de Antioquia, Medellín, Colombia.
Insights
Inappropriate medication and test use in bronchiolitis is common. Longer hospital stays increase this risk, while fever and high white blood cell counts at admission decrease it.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Clinical Pharmacology
Background:
- Bronchiolitis is a common respiratory infection in infants.
- Inappropriate use of medications and diagnostic tests in bronchiolitis is a concern.
- Predictors for this inappropriate use require further investigation.
Purpose of the Study:
- To identify factors associated with the inappropriate use of medications and medical tests in infants hospitalized with bronchiolitis.
- To analyze the prevalence of specific medications and tests prescribed during bronchiolitis admissions.
Main Methods:
- Retrospective study of 1930 infants under two years old admitted with bronchiolitis (January 2015 - December 2018).
- Defined a composite score for inappropriate medication and test use.
- Statistical analysis controlled for potential confounders.
Main Results:
- Nebulized hypertonic saline (92.6%), albuterol (56%), and antibiotics (26.4%) were frequently prescribed.
- Hemogram (95.9%), chest X-rays (92.2%), and C-reactive protein (79.8%) were commonly ordered tests.
- Longer hospital stay increased inappropriate use risk (OR 1.29). Absence of fever (OR 0.22) and leukocytosis (OR 0.09) decreased this risk.
Conclusions:
- Inappropriate use of diagnostic tests and drugs for bronchiolitis is highly prevalent.
- Factors increasing risk include longer hospitalizations.
- Factors decreasing risk include absence of fever and normal white blood cell count upon admission.
Abstract:
Few studies have identified predictors of inappropriate use of medications and medical tests in bronchiolitis. This study aimed to look for potential factors associated with the inappropriate use of medications and tests in bronchiolitis. A retrospective study that included all infants under two years of age in tertiary center admitted due to Bronchiolitis from January 2015 to December 2018. We defined a composite score as the main outcome variable. 1930 patients were included. The most prescribed medications were nebulized hypertonic saline in 1789 patients (92.6%), albuterol (56%), and β-lactam antibiotics (26.4%). The medical tests more commonly ordered were hemogram (95.9%), chest X-rays (92.2%) and C-reactive protein (79.8%). After controlling for potential confounders, it was found that the length of hospital stay increases the risk of the inappropriate use of medications and tests (OR 1.29; CI 95% 1.01-1.65), whereas fever (OR 0.22; CI 95% 0.06-0.71) and leukocytosis (> 15,000/μL) (OR 0.09; CI 95% 0.03-0.32) at admission decrease the risk of the inappropriate use of medications and tests. Inappropriate use of diagnostic tests and drugs for bronchiolitis was a highly prevalent outcome in our population. Patients with longer hospitalizations, absence of fever and a normal white blood cell count at admission, were at increased risk of inappropriate use of medications and medical tests.
More Related Videos
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment